Thermo Fisher Scientific Inc (NYSE:TMO) Stock Price While Sentiment Improves

September 30, 2018 - By Jack Shaw

Thermo Fisher Scientific Inc. (NYSE:TMO) Logo

Sentiment for Thermo Fisher Scientific Inc (NYSE:TMO)

Thermo Fisher Scientific Inc (NYSE:TMO) institutional sentiment increased to 1.08 in Q2 2018. Its up 0.22, from 0.86 in 2018Q1. The ratio improved, as 456 investment managers increased and started new holdings, while 421 sold and trimmed equity positions in Thermo Fisher Scientific Inc. The investment managers in our partner’s database now possess: 332.19 million shares, up from 331.98 million shares in 2018Q1. Also, the number of investment managers holding Thermo Fisher Scientific Inc in their top 10 holdings decreased from 79 to 74 for a decrease of 5. Sold All: 43 Reduced: 378 Increased: 356 New Position: 100.

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics under Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide. The company has market cap of $98.31 billion. The Company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of new drugs and vaccines, as well as diagnosis of diseases to pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. It has a 41.22 P/E ratio. The Company’s Analytical Instruments segment offers instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories.

The stock decreased 0.10% or $0.24 during the last trading session, reaching $244.08. About 1.54M shares traded or 21.44% up from the average. Thermo Fisher Scientific Inc. (NYSE:TMO) has risen 23.20% since September 30, 2017 and is uptrending. It has outperformed by 7.58% the S&P500.

Analysts await Thermo Fisher Scientific Inc. (NYSE:TMO) to report earnings on October, 24. They expect $2.55 EPS, up 10.39 % or $0.24 from last year’s $2.31 per share. TMO’s profit will be $1.03 billion for 23.93 P/E if the $2.55 EPS becomes a reality. After $2.75 actual EPS reported by Thermo Fisher Scientific Inc. for the previous quarter, Wall Street now forecasts -7.27 % negative EPS growth.

Napier Park Global Capital (Us) Lp holds 16.29% of its portfolio in Thermo Fisher Scientific Inc. for 15,000 shares. Cryder Capital Partners Llp owns 408,643 shares or 13.83% of their US portfolio. Moreover, Veritas Investment Management Llp has 9.96% invested in the company for 387,209 shares. The United Kingdom-based Caledonia Investments Plc has invested 9.5% in the stock. Veritas Investment Management (Uk) Ltd, a United Kingdom-based fund reported 114,760 shares.

Since January 1, 0001, it had 0 insider purchases, and 4 sales for $21.13 million activity.

Thermo Fisher Scientific Inc. (NYSE:TMO) Ratings Coverage

Ratings analysis reveals 67% of Thermo Fisher Scientific’s analysts are positive. Out of 3 Wall Street analysts rating Thermo Fisher Scientific, 2 give it “Buy”, 0 “Sell” rating, while 1 recommend “Hold”. The lowest target is $216 while the high is $275. The stock’s average target of $223.33 is -8.50% below today’s ($244.08) share price. TMO was included in 6 notes of analysts from April 11, 2018. The stock of Thermo Fisher Scientific Inc. (NYSE:TMO) has “Overweight” rating given on Monday, September 24 by Barclays Capital. The firm has “Overweight” rating by Morgan Stanley given on Friday, July 13. As per Thursday, July 26, the company rating was maintained by Morgan Stanley. The firm has “Neutral” rating given on Monday, September 17 by Goldman Sachs. The firm has “Overweight” rating given on Thursday, April 26 by Morgan Stanley. The firm has “Overweight” rating given on Wednesday, April 11 by Morgan Stanley.

More recent Thermo Fisher Scientific Inc. (NYSE:TMO) news were published by: Seekingalpha.com which released: “Premarket analyst action – healthcare” on September 17, 2018. Also Seekingalpha.com published the news titled: “Thermo Fisher in-licenses CRISPR technologies” on September 18, 2018. Bizjournals.com‘s news article titled: “George Hatsopoulos, ‘brilliant scientist’ who helped shape Mass. tech economy, dies at 91” with publication date: September 28, 2018 was also an interesting one.

Thermo Fisher Scientific Inc. (NYSE:TMO) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: